Other News To Note
Cellerant Therapeutics Inc., of San Carlos, Calif., said it was awarded a Small Business Innovation Research Phase I contract and a Phase II option from the National Cancer Institute valued up to about $1.7 billion.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST